Related Experiment Video
Updated: Jun 15, 2026

Combinatorial Synthesis of and High-throughput Protein Release from Polymer Film and Nanoparticle Libraries
Published on: September 6, 2012
Polymer-Antimicrobial Peptide Constructs with Tailored Drug-Release Behavior.
Robert Pola1, Matěj Vícha1, Jiří Trousil1
1Institute of Macromolecular Chemistry, Czech Academy of Sciences, Heyrovského nám. 2, 162 00 Prague, Czech Republic.
Polymer-bound antimicrobial peptides show potential against resistant bacteria. pH-sensitive release enhances peptide efficacy, offering a promising strategy to combat microbial resistance.
Area of Science:
- Biochemistry
- Materials Science
- Microbiology
Background:
- Antimicrobial peptides (AMPs) offer a novel strategy against microbial resistance.
- Clinical application of AMPs is limited by stability, toxicity, and immunogenicity.
- Polymer-peptide constructs aim to improve AMP delivery and efficacy.
Purpose of the Study:
- To design, synthesize, and evaluate polymer-antibacterial peptide constructs.
- To investigate pH-sensitive and enzymatically-driven release mechanisms for AMPs.
- To assess the antibacterial activity of polymer-AMP constructs against resistant bacteria.
Main Methods:
- Synthesis of polymer-oligopeptide constructs using biodegradable spacers.
- Determination of minimum inhibitory concentrations (MICs).
- Fluorescence and transmission electron microscopy (TEM) for mechanism analysis.
Main Results:
- The oligopeptide (PEP) demonstrated antibacterial activity against Gram-positive and Gram-negative bacteria by disrupting cell walls.
- PEP retained partial antibacterial efficacy against *Staphylococcus epidermidis*, *Escherichia coli*, and *Acinetobacter baumanii* when polymer-bound.
- pH-sensitive release of PEP at decreased pH restored antibacterial activity comparable to free PEP.
- Enzymatically-driven release was less effective than pH-sensitive release.
Conclusions:
- Polymer-AMP constructs offer a viable approach to enhance antimicrobial peptide delivery.
- pH-sensitive release is a more effective strategy for reactivating AMPs compared to enzymatic release.
- This approach holds potential for developing new treatments against drug-resistant microbial infections.
Related Concept Videos
Modified-Release Drug Delivery Systems: Rate-Programmed II
Modified-Release Drug Delivery Systems: Classification
Modified-Release Drug Delivery Systems: Rate-Programmed I
Modified-Release Drug Delivery Systems: Stimuli-Activated
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Oral Drug Delivery Systems: Delayed-Release Systems

